A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...
Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
News-Medical.Net on MSN
CRISPR-Cas3: A safer gene-editing tool shows promise for transthyretin amyloidosis treatment
Genetic disorders occur due to alterations in the primary genetic material, deoxyribonucleic acid (DNA), of an organism.
Earlier this month, CRISPR Therapeutics presented at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, ...
CRISPR–Cas9-based therapies are widely investigated for their clinical applications. However, there are limitations ...
The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...
A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...
Morning Overview on MSN
New CRISPR technique flips genes on without cutting DNA
Researchers have unveiled a way to flip genes back on without slicing into the genome, a shift that could make CRISPR far ...
Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.
Zacks Investment Research on MSN
Investors heavily search CRISPR Therapeutics AG (CRSP): Here is what you need to know
CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results